APO Research
Talk to an analyst

APO RESEARCH · REPORT

Burosumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Burosumab Market Analysis and Forecast 2026-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchBurosumab Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Burosumab Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Burosumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Burosumab Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Burosumab Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Burosumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Burosumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Burosumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Burosumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Burosumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Burosumab include Ultragenyx and Kyowa Kirin Co.,Ltd. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Burosumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Burosumab, also provides the sales of main regions and countries. Of the upcoming market potential for Burosumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Burosumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Burosumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Burosumab sales, projected growth trends, production technology, application and end-user industry.

Burosumab Segment by Company

Ultragenyx

Kyowa Kirin Co.,Ltd.

Burosumab Segment by Type

10mg/mL

20mg/mL

30mg/mL

Burosumab Segment by Application

Minor Patients Over 1 Year Old

Adult Patients

Burosumab Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Burosumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Burosumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Burosumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Burosumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Burosumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Burosumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Burosumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg/mL Major Manufacturers Table 3. 20mg/mL Major Manufacturers Table 4. 30mg/mL Major Manufacturers Table 5. Global Burosumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Minor Patients Over 1 Year Old Major Manufacturers Table 7. Adult Patients Major Manufacturers Table 8. Burosumab Industry Trends Table 9. Burosumab Industry Drivers Table 10. Burosumab Industry Opportunities and Challenges Table 11. Burosumab Industry Restraints Table 12. Global Burosumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Burosumab Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Burosumab Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Burosumab Revenue Market Share by Region (2021-2026) Table 16. Global Burosumab Revenue Market Share by Region (2027-2032) Table 17. Global Burosumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Burosumab Sales by Region (2021-2026) & (K Units) Table 19. Global Burosumab Sales by Region (2027-2032) & (K Units) Table 20. Global Burosumab Sales Market Share by Region (2021-2026) Table 21. Global Burosumab Sales Market Share by Region (2027-2032) Table 22. Global Burosumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Burosumab Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Burosumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Burosumab Sales Market Share by Manufacturers (2021-2026) Table 26. Global Burosumab Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Burosumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Burosumab Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Burosumab Manufacturers, Product Type & Application Table 30. Global Burosumab Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Burosumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Burosumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Burosumab Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Burosumab Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Burosumab Revenue Market Share by Type (2021-2026) Table 37. Global Burosumab Revenue Market Share by Type (2027-2032) Table 38. Global Burosumab Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Burosumab Sales by Type (2021-2026) & (K Units) Table 40. Global Burosumab Sales by Type (2027-2032) & (K Units) Table 41. Global Burosumab Sales Market Share by Type (2021-2026) Table 42. Global Burosumab Sales Market Share by Type (2027-2032) Table 43. Global Burosumab Price by Type (2021-2026) & (US$/Unit) Table 44. Global Burosumab Price by Type (2027-2032) & (US$/Unit) Table 45. Global Burosumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Burosumab Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Burosumab Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Burosumab Revenue Market Share by Application (2021-2026) Table 49. Global Burosumab Revenue Market Share by Application (2027-2032) Table 50. Global Burosumab Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Burosumab Sales by Application (2021-2026) & (K Units) Table 52. Global Burosumab Sales by Application (2027-2032) & (K Units) Table 53. Global Burosumab Sales Market Share by Application (2021-2026) Table 54. Global Burosumab Sales Market Share by Application (2027-2032) Table 55. Global Burosumab Price by Application (2021-2026) & (US$/Unit) Table 56. Global Burosumab Price by Application (2027-2032) & (US$/Unit) Table 57. Ultragenyx Company Information Table 58. Ultragenyx Business Overview Table 59. Ultragenyx Burosumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Ultragenyx Burosumab Product Portfolio Table 61. Ultragenyx Recent Development Table 62. Kyowa Kirin Co.,Ltd. Company Information Table 63. Kyowa Kirin Co.,Ltd. Business Overview Table 64. Kyowa Kirin Co.,Ltd. Burosumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Kyowa Kirin Co.,Ltd. Burosumab Product Portfolio Table 66. Kyowa Kirin Co.,Ltd. Recent Development Table 67. North America Burosumab Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Burosumab Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Burosumab Sales by Type (2021-2026) & (K Units) Table 70. North America Burosumab Sales by Type (2027-2032) & (K Units) Table 71. North America Burosumab Sales Price by Type (2021-2026) & (US$/Unit) Table 72. North America Burosumab Sales Price by Type (2027-2032) & (US$/Unit) Table 73. North America Burosumab Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Burosumab Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Burosumab Sales by Application (2021-2026) & (K Units) Table 76. North America Burosumab Sales by Application (2027-2032) & (K Units) Table 77. North America Burosumab Sales Price by Application (2021-2026) & (US$/Unit) Table 78. North America Burosumab Sales Price by Application (2027-2032) & (US$/Unit) Table 79. North America Burosumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Burosumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Burosumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Burosumab Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 83. North America Burosumab Sales by Country (2021-2026) & (K Units) Table 84. North America Burosumab Sales by Country (2027-2032) & (K Units) Table 85. North America Burosumab Sales Price by Country (2021-2026) & (US$/Unit) Table 86. North America Burosumab Sales Price by Country (2027-2032) & (US$/Unit) Table 87. United States Burosumab Revenue (2021-2032) & (US$ Million) Table 88. Canada Burosumab Revenue (2021-2032) & (US$ Million) Table 89. Europe Burosumab Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Burosumab Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Burosumab Sales by Type (2021-2026) & (K Units) Table 92. Europe Burosumab Sales by Type (2027-2032) & (K Units) Table 93. Europe Burosumab Sales Price by Type (2021-2026) & (US$/Unit) Table 94. Europe Burosumab Sales Price by Type (2027-2032) & (US$/Unit) Table 95. Europe Burosumab Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Burosumab Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Burosumab Sales by Application (2021-2026) & (K Units) Table 98. Europe Burosumab Sales by Application (2027-2032) & (K Units) Table 99. Europe Burosumab Sales Price by Application (2021-2026) & (US$/Unit) Table 100. Europe Burosumab Sales Price by Application (2027-2032) & (US$/Unit) Table 101. Europe Burosumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Burosumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. Europe Burosumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. Europe Burosumab Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 105. Europe Burosumab Sales by Country (2021-2026) & (K Units) Table 106. Europe Burosumab Sales by Country (2027-2032) & (K Units) Table 107. Europe Burosumab Sales Price by Country (2021-2026) & (US$/Unit) Table 108. Europe Burosumab Sales Price by Country (2027-2032) & (US$/Unit) Table 109. Germany Burosumab Revenue (2021-2032) & (US$ Million) Table 110. France Burosumab Revenue (2021-2032) & (US$ Million) Table 111. U.K. Burosumab Revenue (2021-2032) & (US$ Million) Table 112. Italy Burosumab Revenue (2021-2032) & (US$ Million) Table 113. Netherlands Burosumab Revenue (2021-2032) & (US$ Million) Table 114. China Burosumab Revenue by Type (2021-2026) & (US$ Million) Table 115. China Burosumab Revenue by Type (2027-2032) & (US$ Million) Table 116. China Burosumab Sales by Type (2021-2026) & (K Units) Table 117. China Burosumab Sales by Type (2027-2032) & (K Units) Table 118. China Burosumab Sales Price by Type (2021-2026) & (US$/Unit) Table 119. China Burosumab Sales Price by Type (2027-2032) & (US$/Unit) Table 120. China Burosumab Revenue by Application (2021-2026) & (US$ Million) Table 121. China Burosumab Revenue by Application (2027-2032) & (US$ Million) Table 122. China Burosumab Sales by Application (2021-2026) & (K Units) Table 123. China Burosumab Sales by Application (2027-2032) & (K Units) Table 124. China Burosumab Sales Price by Application (2021-2026) & (US$/Unit) Table 125. China Burosumab Sales Price by Application (2027-2032) & (US$/Unit) Table 126. Asia Burosumab Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Burosumab Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Burosumab Sales by Type (2021-2026) & (K Units) Table 129. Asia Burosumab Sales by Type (2027-2032) & (K Units) Table 130. Asia Burosumab Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Asia Burosumab Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Asia Burosumab Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Burosumab Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Burosumab Sales by Application (2021-2026) & (K Units) Table 135. Asia Burosumab Sales by Application (2027-2032) & (K Units) Table 136. Asia Burosumab Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Asia Burosumab Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Asia Burosumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Burosumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Burosumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Burosumab Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 142. Asia Burosumab Sales by Country (2021-2026) & (K Units) Table 143. Asia Burosumab Sales by Country (2027-2032) & (K Units) Table 144. Asia Burosumab Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Asia Burosumab Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Japan Burosumab Revenue (2021-2032) & (US$ Million) Table 147. South Korea Burosumab Revenue (2021-2032) & (US$ Million) Table 148. India Burosumab Revenue (2021-2032) & (US$ Million) Table 149. Australia Burosumab Revenue (2021-2032) & (US$ Million) Table 150. China Taiwan Burosumab Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Burosumab Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Burosumab Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Burosumab Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Burosumab Sales by Type (2021-2026) & (K Units) Table 155. SAMEA Burosumab Sales by Type (2027-2032) & (K Units) Table 156. SAMEA Burosumab Sales Price by Type (2021-2026) & (US$/Unit) Table 157. SAMEA Burosumab Sales Price by Type (2027-2032) & (US$/Unit) Table 158. SAMEA Burosumab Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Burosumab Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Burosumab Sales by Application (2021-2026) & (K Units) Table 161. SAMEA Burosumab Sales by Application (2027-2032) & (K Units) Table 162. SAMEA Burosumab Sales Price by Application (2021-2026) & (US$/Unit) Table 163. SAMEA Burosumab Sales Price by Application (2027-2032) & (US$/Unit) Table 164. SAMEA Burosumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Burosumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Burosumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Burosumab Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. SAMEA Burosumab Sales by Country (2021-2026) & (K Units) Table 169. SAMEA Burosumab Sales by Country (2027-2032) & (K Units) Table 170. SAMEA Burosumab Sales Price by Country (2021-2026) & (US$/Unit) Table 171. SAMEA Burosumab Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Brazil Burosumab Revenue (2021-2032) & (US$ Million) Table 173. Argentina Burosumab Revenue (2021-2032) & (US$ Million) Table 174. Chile Burosumab Revenue (2021-2032) & (US$ Million) Table 175. Colombia Burosumab Revenue (2021-2032) & (US$ Million) Table 176. Peru Burosumab Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Burosumab Revenue (2021-2032) & (US$ Million) Table 178. Israel Burosumab Revenue (2021-2032) & (US$ Million) Table 179. UAE Burosumab Revenue (2021-2032) & (US$ Million) Table 180. Turkey Burosumab Revenue (2021-2032) & (US$ Million) Table 181. Iran Burosumab Revenue (2021-2032) & (US$ Million) Table 182. Egypt Burosumab Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Burosumab Distributors List Table 186. Burosumab Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Burosumab Image Figure 2. Global Burosumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Burosumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg/mL Image Figure 5. 20mg/mL Image Figure 6. 30mg/mL Image Figure 7. Global Burosumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Burosumab Market Size Share 2021 VS 2025 VS 2032 Figure 9. Minor Patients Over 1 Year Old Image Figure 10. Adult Patients Image Figure 11. Global Burosumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Burosumab Revenue (2021-2032) & (US$ Million) Figure 13. Global Burosumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Burosumab Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Burosumab Revenue Market Share by Region (2021-2032) Figure 16. Global Burosumab Sales (2021-2032) & (K Units) Figure 17. Global Burosumab Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Burosumab Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Burosumab Sales YoY (2021-2032) & (K Units) Figure 20. Europe Burosumab Sales YoY (2021-2032) & (K Units) Figure 21. China Burosumab Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Burosumab Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Burosumab Sales YoY (2021-2032) & (K Units) Figure 24. Global Burosumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Burosumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Burosumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Burosumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Burosumab Revenue Market Share by Type (2021-2032) Figure 30. Global Burosumab Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Burosumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Burosumab Sales Market Share by Type (2021-2032) Figure 33. Global Burosumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Burosumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Burosumab Revenue Market Share by Application (2021-2032) Figure 36. Global Burosumab Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Burosumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Burosumab Sales Market Share by Application (2021-2032) Figure 39. North America Burosumab Revenue Share by Type (2021-2032) Figure 40. North America Burosumab Sales Share by Type (2021-2032) Figure 41. North America Burosumab Revenue Share by Application (2021-2032) Figure 42. North America Burosumab Sales Share by Application (2021-2032) Figure 43. North America Burosumab Revenue Share by Country (2021-2032) Figure 44. North America Burosumab Sales Share by Country (2021-2032) Figure 45. Europe Burosumab Revenue Share by Type (2021-2032) Figure 46. Europe Burosumab Sales Share by Type (2021-2032) Figure 47. Europe Burosumab Revenue Share by Application (2021-2032) Figure 48. Europe Burosumab Sales Share by Application (2021-2032) Figure 49. Europe Burosumab Revenue Share by Country (2021-2032) Figure 50. Europe Burosumab Sales Share by Country (2021-2032) Figure 51. China Burosumab Revenue Share by Type (2021-2032) Figure 52. China Burosumab Sales Share by Type (2021-2032) Figure 53. China Burosumab Revenue Share by Application (2021-2032) Figure 54. China Burosumab Sales Share by Application (2021-2032) Figure 55. Asia Burosumab Revenue Share by Type (2021-2032) Figure 56. Asia Burosumab Sales Share by Type (2021-2032) Figure 57. Asia Burosumab Revenue Share by Application (2021-2032) Figure 58. Asia Burosumab Sales Share by Application (2021-2032) Figure 59. Asia Burosumab Revenue Share by Country (2021-2032) Figure 60. Asia Burosumab Sales Share by Country (2021-2032) Figure 61. SAMEA Burosumab Revenue Share by Type (2021-2032) Figure 62. SAMEA Burosumab Sales Share by Type (2021-2032) Figure 63. SAMEA Burosumab Revenue Share by Application (2021-2032) Figure 64. SAMEA Burosumab Sales Share by Application (2021-2032) Figure 65. SAMEA Burosumab Revenue Share by Country (2021-2032) Figure 66. SAMEA Burosumab Sales Share by Country (2021-2032) Figure 67. Burosumab Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Burosumab Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/mL
  • 20mg/mL
  • 30mg/mL
Applications
  • Minor Patients Over 1 Year Old
  • Adult Patients
Companies covered
  • Ultragenyx
  • Kyowa Kirin Co.,Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Burosumab Market by Type
  3. 1.2.1 Global Burosumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg/mL
  5. 1.2.3 20mg/mL
  6. 1.2.4 30mg/mL
  7. 1.3 Burosumab Market by Application
  8. 1.3.1 Global Burosumab Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Minor Patients Over 1 Year Old
  10. 1.3.3 Adult Patients
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Burosumab Market Dynamics
  1. 2.1 Burosumab Industry Trends
  2. 2.2 Burosumab Industry Drivers
  3. 2.3 Burosumab Industry Opportunities and Challenges
  4. 2.4 Burosumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Burosumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Burosumab Revenue by Region
  3. 3.2.1 Global Burosumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Burosumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Burosumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Burosumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Burosumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Burosumab Sales by Region
  9. 3.4.1 Global Burosumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Burosumab Sales by Region (2021-2026)
  11. 3.4.3 Global Burosumab Sales by Region (2027-2032)
  12. 3.4.4 Global Burosumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Burosumab Revenue by Manufacturers
  2. 4.1.1 Global Burosumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Burosumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Burosumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Burosumab Sales by Manufacturers
  6. 4.2.1 Global Burosumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Burosumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Burosumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Burosumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Burosumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Burosumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Burosumab Manufacturers, Product Type & Application
  13. 4.7 Global Burosumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Burosumab Market CR5 and HHI
  16. 4.8.2 2025 Burosumab Tier 1, Tier 2, and Tier 3
5 Burosumab Market by Type
  1. 5.1 Global Burosumab Revenue by Type
  2. 5.1.1 Global Burosumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Burosumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Burosumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Burosumab Sales by Type
  6. 5.2.1 Global Burosumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Burosumab Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Burosumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Burosumab Price by Type
6 Burosumab Market by Application
  1. 6.1 Global Burosumab Revenue by Application
  2. 6.1.1 Global Burosumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Burosumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Burosumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Burosumab Sales by Application
  6. 6.2.1 Global Burosumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Burosumab Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Burosumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Burosumab Price by Application
7 Company Profiles
  1. 7.1 Ultragenyx
  2. 7.1.1 Ultragenyx Company Information
  3. 7.1.2 Ultragenyx Business Overview
  4. 7.1.3 Ultragenyx Burosumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Ultragenyx Burosumab Product Portfolio
  6. 7.1.5 Ultragenyx Recent Developments
  7. 7.2 Kyowa Kirin Co.,Ltd.
  8. 7.2.1 Kyowa Kirin Co.,Ltd. Company Information
  9. 7.2.2 Kyowa Kirin Co.,Ltd. Business Overview
  10. 7.2.3 Kyowa Kirin Co.,Ltd. Burosumab Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kyowa Kirin Co.,Ltd. Burosumab Product Portfolio
  12. 7.2.5 Kyowa Kirin Co.,Ltd. Recent Developments
8 North America
  1. 8.1 North America Burosumab Market Size by Type
  2. 8.1.1 North America Burosumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Burosumab Sales by Type (2021-2032)
  4. 8.1.3 North America Burosumab Price by Type (2021-2032)
  5. 8.2 North America Burosumab Market Size by Application
  6. 8.2.1 North America Burosumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Burosumab Sales by Application (2021-2032)
  8. 8.2.3 North America Burosumab Price by Application (2021-2032)
  9. 8.3 North America Burosumab Market Size by Country
  10. 8.3.1 North America Burosumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Burosumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Burosumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Burosumab Market Size by Type
  2. 9.1.1 Europe Burosumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Burosumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Burosumab Price by Type (2021-2032)
  5. 9.2 Europe Burosumab Market Size by Application
  6. 9.2.1 Europe Burosumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Burosumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Burosumab Price by Application (2021-2032)
  9. 9.3 Europe Burosumab Market Size by Country
  10. 9.3.1 Europe Burosumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Burosumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Burosumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Burosumab Market Size by Type
  2. 10.1.1 China Burosumab Revenue by Type (2021-2032)
  3. 10.1.2 China Burosumab Sales by Type (2021-2032)
  4. 10.1.3 China Burosumab Price by Type (2021-2032)
  5. 10.2 China Burosumab Market Size by Application
  6. 10.2.1 China Burosumab Revenue by Application (2021-2032)
  7. 10.2.2 China Burosumab Sales by Application (2021-2032)
  8. 10.2.3 China Burosumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Burosumab Market Size by Type
  2. 11.1.1 Asia Burosumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Burosumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Burosumab Price by Type (2021-2032)
  5. 11.2 Asia Burosumab Market Size by Application
  6. 11.2.1 Asia Burosumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Burosumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Burosumab Price by Application (2021-2032)
  9. 11.3 Asia Burosumab Market Size by Country
  10. 11.3.1 Asia Burosumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Burosumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Burosumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Burosumab Market Size by Type
  2. 12.1.1 SAMEA Burosumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Burosumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Burosumab Price by Type (2021-2032)
  5. 12.2 SAMEA Burosumab Market Size by Application
  6. 12.2.1 SAMEA Burosumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Burosumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Burosumab Price by Application (2021-2032)
  9. 12.3 SAMEA Burosumab Market Size by Country
  10. 12.3.1 SAMEA Burosumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Burosumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Burosumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Burosumab Value Chain Analysis
  2. 13.1.1 Burosumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Burosumab Production Mode & Process
  6. 13.2 Burosumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Burosumab Distributors
  9. 13.2.3 Burosumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst